XBiotech Inc.
XBIT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $5 | $5 | $12 | $8 |
| G&A Expenses | $0 | $1 | $2 | $1 |
| SG&A Expenses | $1 | $1 | $2 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6 | $6 | $14 | $9 |
| Operating Income | -$6 | -$6 | -$14 | -$9 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $5 | $3 | -$2 |
| Pre-Tax Income | -$6 | -$2 | -$11 | -$11 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$6 | -$2 | -$11 | -$11 |
| % Margin | – | – | – | – |
| EPS | -0.2 | -0.058 | -0.36 | -0.34 |
| % Growth | -247.2% | 84% | -5.9% | – |
| EPS Diluted | -0.2 | -0.058 | -0.36 | -0.34 |
| Weighted Avg Shares Out | 30 | 30 | 30 | 30 |
| Weighted Avg Shares Out Dil | 30 | 30 | 30 | 30 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $2 | $2 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$5 | -$1 | -$10 | -$10 |
| % Margin | – | – | – | – |